J. Brès

545 total citations
23 papers, 455 citations indexed

About

J. Brès is a scholar working on Pharmacology, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, J. Brès has authored 23 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Analytical Chemistry and 3 papers in Molecular Biology. Recurrent topics in J. Brès's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Analytical Methods in Pharmaceuticals (10 papers) and Pharmacology and Obesity Treatment (4 papers). J. Brès is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Analytical Methods in Pharmaceuticals (10 papers) and Pharmacology and Obesity Treatment (4 papers). J. Brès collaborates with scholars based in France, United States and Poland. J. Brès's co-authors include Françoise Bressolle, Edward R. Garrett, Peter H. Hinderling, Roberto Goméni, G. Marti-Mestres, Laurence Vian, José Ramos, Sabine Martin, Isabelle Solassol and Людас Іванаускас and has published in prestigious journals such as Journal of Chromatography A, Clinical Chemistry and International Journal of Pharmaceutics.

In The Last Decade

J. Brès

23 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Brès France 13 157 111 81 69 50 23 455
H Jaeger Germany 13 102 0.6× 126 1.1× 77 1.0× 43 0.6× 52 1.0× 58 487
Y. Shiobara United Kingdom 11 102 0.6× 92 0.8× 91 1.1× 84 1.2× 93 1.9× 22 409
R.R. Brodie United States 15 84 0.5× 135 1.2× 66 0.8× 77 1.1× 76 1.5× 42 570
P. J. Pentik�inen Finland 8 81 0.5× 70 0.6× 48 0.6× 42 0.6× 73 1.5× 9 379
Janis J. MacKichan United States 12 107 0.7× 72 0.6× 79 1.0× 57 0.8× 71 1.4× 30 435
Morris Pfeffer United States 14 206 1.3× 65 0.6× 97 1.2× 83 1.2× 69 1.4× 20 634
T. W. Guentert Switzerland 15 233 1.5× 53 0.5× 71 0.9× 95 1.4× 157 3.1× 28 517
Tung-Hu Tsai Taiwan 12 176 1.1× 52 0.5× 107 1.3× 62 0.9× 63 1.3× 18 402
DB Jack United Kingdom 15 153 1.0× 145 1.3× 70 0.9× 82 1.2× 152 3.0× 40 609
Chii‐Ming Lai United States 14 107 0.7× 106 1.0× 99 1.2× 52 0.8× 116 2.3× 36 660

Countries citing papers authored by J. Brès

Since Specialization
Citations

This map shows the geographic impact of J. Brès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Brès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Brès more than expected).

Fields of papers citing papers by J. Brès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Brès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Brès. The network helps show where J. Brès may publish in the future.

Co-authorship network of co-authors of J. Brès

This figure shows the co-authorship network connecting the top 25 collaborators of J. Brès. A scholar is included among the top collaborators of J. Brès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Brès. J. Brès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solassol, Isabelle, et al.. (2008). HPLC with UV or Mass Spectrometric Detection for Quantifying Endogenous Uracil and Dihydrouracil in Human Plasma. Clinical Chemistry. 54(9). 1463–1472. 21 indexed citations
2.
Marti-Mestres, G., et al.. (2006). The “in vitro” percutaneous penetration of three antioxidant compounds. International Journal of Pharmaceutics. 331(1). 139–144. 48 indexed citations
3.
Azay, Jacqueline, J. Brès, Mirosław Krośniak, et al.. (2001). Vanadium pharmacokinetics and oral bioavailability upon single‐dose administration of vanadyl sulfate to rats. Fundamental and Clinical Pharmacology. 15(5). 313–324. 19 indexed citations
4.
Bressolle, Françoise, et al.. (1996). Nonlinear Pharmacokinetics of High-Dose Thiopental Following Long Term Treatment. Clinical Drug Investigation. 11(1). 32–42. 12 indexed citations
5.
Hillaire‐Buys, Dominique, Hélène Peyrière, E. Lobjoie, et al.. (1995). Influence of arterio‐venous haemofiltration on teicoplanin elimination.. British Journal of Clinical Pharmacology. 40(1). 95–97. 9 indexed citations
6.
Audran, Michel, et al.. (1993). Displacement of Thiopental from Human Serum Albumin by Associated Drugs. Journal of Pharmaceutical Sciences. 82(5). 493–497. 14 indexed citations
7.
Bressolle, Françoise, et al.. (1992). Absolute Bioavailability, Rate of Absorption, and Dose Proportionality of Sulpiride in Humans. Journal of Pharmaceutical Sciences. 81(1). 26–32. 39 indexed citations
8.
Cociglio, M., et al.. (1991). Pharmacokinetics of an indomethacin pro-drug: Apyramide after intravenous administration in dog. European Journal of Drug Metabolism and Pharmacokinetics. 16(4). 275–280. 7 indexed citations
9.
Brès, J., et al.. (1991). Pharmacokinetics of Sulpiride in Humans after Intravenous and Intramuscular Administrations. Journal of Pharmaceutical Sciences. 80(12). 1119–1124. 19 indexed citations
11.
Bressolle, Françoise, J. Brès, & G. Mourad. (1989). Pharmacokinetics of Sulpiride After Intravenous Administration in Patients with Impaired Renal Function. Clinical Pharmacokinetics. 17(5). 367–373. 13 indexed citations
12.
Brès, J., et al.. (1986). [Plasma, erythrocyte and urinary pharmacokinetics of sultopride in man].. PubMed. 40(6). 433–9. 2 indexed citations
13.
Bressolle, Françoise, et al.. (1985). Quantitative Thin-Layer and High-Performance Liquid Chromatographic Determination of Lorapride in Biological Fluids and a Pharmacokinetic study in Humans. Journal of Pharmaceutical Sciences. 74(11). 1215–1218. 3 indexed citations
14.
Brès, J., et al.. (1985). [Determination of sulpiride and sultopride by high-performance liquid chromatography for pharmacokinetic studies].. PubMed. 341(2). 391–9. 30 indexed citations
15.
Brès, J., et al.. (1985). High-performance liquid chromatographic determination of a new benzamide in biological fluids for use in a human pharmacokinetic study. Journal of Chromatography B Biomedical Sciences and Applications. 343(2). 443–448. 3 indexed citations
16.
Bressolle, Françoise & J. Brès. (1985). Dosage du sulpiride et du sultopride par chromatographie liquide à haute performance en vue de leur étude pharmacocinetique. Journal of Chromatography B Biomedical Sciences and Applications. 341. 391–399. 30 indexed citations
17.
Brès, J., et al.. (1984). Sulpiride Pharmacokinetics in Humans After Intramuscular Administration at Three Dose Levels. Journal of Pharmaceutical Sciences. 73(8). 1128–1136. 43 indexed citations
18.
Bressolle, Françoise, et al.. (1979). Dosage des médicaments par spectrophotométrie in situ des chromatogrammes en vue de leur étude pharmacocinétique : I. Sulpiride et autres benzamides, vincamine, naftazone. Journal of Chromatography A. 174(2). 421–433. 2 indexed citations
19.
Bressolle, Françoise, et al.. (1979). Dosage des médicaments par spectrophotométrie in situ des chromatogrammes en vue de leur étude pharmacocinétique. Journal of Chromatography A. 174(2). 421–433. 16 indexed citations
20.
Hinderling, Peter H., J. Brès, & Edward R. Garrett. (1974). Protein Binding and Erythrocyte Partitioning of Disopyramide and Its Monodealkylated Metabolite. Journal of Pharmaceutical Sciences. 63(11). 1684–1690. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026